RetiPharma IVS — Credit Rating and Financial Key Figures
CVR number: 37134120
Ole Maaløes Vej 3, 2200 København N
Income statement (kDKK)
2018 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| Gross profit | - 147.05 |
| Employee benefit expenses | -11.31 |
| EBIT | - 158.36 |
| Other financial income | - 105.93 |
| Pre-tax profit | - 264.29 |
| Income taxes | 60.42 |
| Net earnings | - 203.87 |
Assets (kDKK)
2016 | 2017 | 2018 | |
|---|---|---|---|
| Development expenditure | 1 222.45 | ||
| Intangible assets total | 1 222.45 | ||
| Tangible assets total | |||
| Investments total | |||
| Long term receivables total | |||
| Inventories total | |||
| Current other receivables | 27.79 | ||
| Current deferred tax assets | 272.97 | ||
| Short term receivables total | 300.76 | ||
| Cash and bank deposits | 0.00 | 0.00 | 5 059.14 |
| Cash and cash equivalents | 0.00 | 0.00 | 5 059.14 |
| Balance sheet total (assets) | 0.00 | 0.00 | 6 582.36 |
Equity and liabilities (kDKK)
2016 | 2017 | 2018 | |
|---|---|---|---|
| Share capital | 0.00 | 0.00 | 6.82 |
| Other reserves | 953.51 | ||
| Retained earnings | - 946.89 | ||
| Profit of the financial year | - 203.87 | ||
| Shareholders equity total | 0.00 | 0.00 | - 190.44 |
| Provisions | 212.56 | ||
| Non-current loans from credit institutions | 6 089.59 | ||
| Non-current accruals and deferred income | 121.50 | ||
| Non-current other liabilities | - 121.50 | ||
| Non-current liabilities total | 6 089.59 | ||
| Current trade creditors | 135.18 | ||
| Other non-interest bearing current liabilities | 335.47 | ||
| Current liabilities total | 470.65 | ||
| Balance sheet total (liabilities) | 0.00 | 0.00 | 6 582.36 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.